BlackRock’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
BlackRock's SOPH Position: Q2 2026 in Review
BlackRock held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 5,086 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5295.
BlackRock first reported a position in SOPH in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.38M in Q3 2021. 71 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- BlackRock held 5,086 shares of SOPHiA GENETICS worth $29.3K as of Q2 2026.
- BlackRock left its SOPHiA GENETICS share count unchanged in Q2 2026.
- SOPHiA GENETICS made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5295 holding.
- BlackRock first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 20 quarters since.
- BlackRock's SOPHiA GENETICS position peaked at $5.38M in Q3 2021.
- 71 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.